530 related articles for article (PubMed ID: 15389476)
1. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003).
Aisenberg G; Rolston KV; Safdar A
Cancer; 2004 Nov; 101(9):2134-40. PubMed ID: 15389476
[TBL] [Abstract][Full Text] [Related]
2. [Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature].
Ramos JM; Domine M; Ponte MC; Soriano F
Enferm Infecc Microbiol Clin; 1996; 14(7):436-40. PubMed ID: 8991439
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.
Shie SS; Huang CT; Leu HS
J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676
[TBL] [Abstract][Full Text] [Related]
4. [Achromobacter xylosoxidans bacteremia in a patient with community-acquired pneumonia].
de Fernández MI; Bugarín G; Arévalo CE
Medicina (B Aires); 2001; 61(1):79-80. PubMed ID: 11265630
[TBL] [Abstract][Full Text] [Related]
5. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG
J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070
[TBL] [Abstract][Full Text] [Related]
6. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
[TBL] [Abstract][Full Text] [Related]
7. Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies.
Hernández JA; Martino R; Pericas R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1998 Mar; 83(3):284-5. PubMed ID: 9573685
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to Achromobacter xylosoxidans in patients with cancer.
Legrand C; Anaissie E
Clin Infect Dis; 1992 Feb; 14(2):479-84. PubMed ID: 1554834
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome.
Weitkamp JH; Tang YW; Haas DW; Midha NK; Crowe JE
Clin Infect Dis; 2000 Nov; 31(5):1183-7. PubMed ID: 11073750
[TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection due to Achromobacter xylosoxidans: report of 9 cases.
Tena D; González-Praetorius A; Pérez-Balsalobre M; Sancho O; Bisquert J
Scand J Infect Dis; 2008; 40(2):84-7. PubMed ID: 17852927
[TBL] [Abstract][Full Text] [Related]
12. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
13. Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis.
Chiu SK; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Aug; 41(4):286-93. PubMed ID: 18787734
[TBL] [Abstract][Full Text] [Related]
14. Achromobacter xylosoxidans bacteremia.
Mandell WF; Garvey GJ; Neu HC
Rev Infect Dis; 1987; 9(5):1001-5. PubMed ID: 3317727
[TBL] [Abstract][Full Text] [Related]
15. Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified bacterial pathogens.
Hu HC; Huang CC; Tsai YH; Lee CH; Hsieh MJ
Chang Gung Med J; 2005 Apr; 28(4):229-36. PubMed ID: 16013342
[TBL] [Abstract][Full Text] [Related]
16. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.
Gómez-Cerezo J; Suárez I; Ríos JJ; Peña P; García de Miguel MJ; de José M; Monteagudo O; Linares P; Barbado-Cano A; Vázquez JJ
Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):360-3. PubMed ID: 12750959
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
